Companies · Other Health Care

Radiology Partners Holdings, LLC

El Segundo · Other Health Care · https://radiologypartners.net/

Diligence memoA one-page analyst read on Radiology Partners Holdings, LLC — recommendation, valuation, rhythm, risks.
$1.5B
Total raised · real
11
Rounds
11.5×
Latest step-up
Top 1%
Sector rank · raised
Growth/Late
Latest stage · inferred · Thu Feb 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Radiology Partners Holdings, LLC has raised $1.5B over 11 rounds; too few niche peers to rank its valuation yet.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

At-risk
  • Last raise 2.4 yr ago; this sector typically re-raises about every 14 months.
  • Past due for a raise versus sector cadence — watch for distress or a bridge.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Radiology Partners Holdings, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
12.2 yr record
Peak capital year was 2024 with $719.8M across 1 filings.
Market position
ahead of 100% of Other Health Care peers
Capital scale is ahead of 100% of Other Health Care peers; modeled value is above 100% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Some evidence
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • Capital program peaked in 2024: $719.8M across 1 filings.
  • Largest single filing was $719.8M on 2024-02-22.
  • Filing rows sum to $1.7B, while canonical raised total is $1.5B; likely amendments/superseded rows are mixed into the detail view.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
  • Canonical filtering should be tightened before using row-level totals for diligence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Radiology Partners Holdings, LLC is one of 5377 Other Health Care companies tracked from El Segundo. By capital raised it ranks among the largest (ahead of 100% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

Excellence in Imaging

Excellence in Imaging

Find Radiology Partners – Excellence in Imaging online

Trades publicly as Radiology Partners – Excellence in Imaging.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
7
Investors (latest)
2024-02-22
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$2.5B$5.0B$7.5B$10.0BPre-Seed · 2014-05-09 Raised $477K (real) Modeled valuation $15M (est)Pre-Seed2014Seed · 2016-12-30 Raised $1.8M (real) Modeled valuation $44M (est)Seed2016Series D+ · 2017-05-02 Raised $200M (real) Modeled valuation $4.6B (est)Series D+2017Series D+ · 2018-02-13 Raised $234M (real) Modeled valuation $5.4B (est)Series D+2018Series D+ · 2019-05-10 Raised $48M (real) Modeled valuation $1.1B (est)Series D+2019Series D+ · 2019-06-25 Raised $15M (real) Modeled valuation $336M (est)Series D+2019Series D+ · 2019-06-28 Raised $45M (real) Modeled valuation $1.0B (est)Series D+2019Series D+ · 2021-02-23 Raised $26M (real) Modeled valuation $530M (est)Series D+2021Series D+ · 2021-03-17 Raised $13M (real) Modeled valuation $251M (est)Series D+2021Series C · 2022-06-30 Raised $53M (real) Modeled valuation $719M (est)Series C2022Series D+ · 2022-06-30 Raised $233M (real) Modeled valuation $3.5B (est)Series D+2022Series C · 2022-06-30 Raised $62M (real) Modeled valuation $855M (est)Series C2022Growth/Late · 2024-02-22 Raised $720M (real) Modeled valuation $9.1B (est)Growth/Late2024Cumulative $1.7B

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$477K · 2014
Seed$1.8M · 2016
Series D+$200.0M · 2017no Series A / Series B / Series C on file
Series D+ extension$233.9M · 2018
Series D+ extension$47.7M · 2019
Series D+ extension$14.6M · 2019
Series D+ extension$45.2M · 2019
Series D+ extension$26.4M · 2021
Series D+ extension$12.6M · 2021
Bridge · Series D+-stage$52.5M · 2022smaller follow-on
Series D+ extension$232.7M · 2022
Bridge · Series D+-stage$62.5M · 2022smaller follow-on
Growth/Late$719.8M · 2024

Stages are modeled from round size (public records carry no series label). No record for: Series A, Series B — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 71%.

Modeled valuation trajectory
$9.1B
Base estimate est.
$5.3B
Conservative case
$12.0B
Upside case
$7.2B
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Growth/Latea round over $400M). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $14.7M · 2014-05-092014Seed · modeled $44.5M · 2016-12-30Series D+ · modeled $4.6B · 2017-05-02Series D+ · modeled $5.4B · 2018-02-13Series D+ · modeled $1.1B · 2019-05-10Series D+ · modeled $336.0M · 2019-06-25Series D+ · modeled $1.0B · 2019-06-28Series D+ · modeled $530.4M · 2021-02-23Series D+ · modeled $250.7M · 2021-03-17Series C · modeled $719.1M · 2022-06-30Series D+ · modeled $3.5B · 2022-06-30Series C · modeled $855.4M · 2022-06-30Growth/Late · modeled $9.1B · 2024-02-222024
Model inputs · modeled:benchmark-stage-stepup-v1
10%
Dilution assumption
Implied ownership sold in the financing.
85%
Survival probability
73% low · 91% high
1.19×/yr
Annual markup
1.29×/yr upside case
2.4 yr
Elapsed time used
2.4 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
10 mo
Avg between rounds
$156.8M/yr
Capital velocity
12.2 yr
On record since
2014
First round
13
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 632× above median
This company$1.5B
Sector median$2.4M
Latest round — vs other Growth/Late rounds in sector (real $, this stage) 1.5× above median
This company$719.8M
Sector median$475.0M
Modeled value — vs sector median (estimate, all stages) 413× above median
This company$9.1B
Sector median$22.1M

Raised more than 100% of sector peers (real $). Modeled value above 100% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Growth/Late) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful.

Not enough valued peers in this cohort to chart positioning.

CompanyStageRaised · realValue · estvs peer med.
Radiology Partners Holdings, LLC this companyGrowth/Late$1.5B$9.1B1.82×
Charlotte's Web Holdings, Inc.Growth/Late$483.9M$895.9M0.18×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$477K2014-05-09$2.6M$14.7M85%
Seed$1.8M2016-12-30$9.0M$44.5M90%
Series D+$200.0M2017-05-02$1.7B$4.6B90%
Series D+$233.9M2018-02-13$1.9B$5.4B90%
Series D+$47.7M2019-05-10$397.3M$1.1B90%
Series D+$14.6M2019-06-25$121.7M$336.0M90%
Series D+$45.2M2019-06-28$376.8M$1.0B90%
Series D+$26.4M2021-02-23$219.6M$530.4M90%
Series D+$12.6M2021-03-17$105.1M$250.7M90%
Series C$52.5M2022-06-30$350.2M$719.1M90%
Series D+$232.7M2022-06-30$1.9B$3.5B90%
Series C$62.5M2022-06-30$416.5M$855.4M90%
Growth/Late$719.8M2024-02-22$7.2B$9.1B90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$477K2014-05-09
    • First recorded raise — entered as Pre-Seed.
    • 15 investors on this round.
  2. Seed$1.8M2016-12-30
    • Raised again after 32 mo — slower than the ~14 mo sector norm.
    • Round 3.8× larger than the prior — scaling up.
    • Switched to Rule 506(c) (was Rule 506(b)).
    • 7 investors on this round.
  3. Series D+$200.0M2017-05-02
    • Came back fast: 4 mo vs the ~14 mo sector norm.
    • Round 111.4× larger than the prior — scaling up.
    • Switched to Rule 506(b) (was Rule 506(c)).
    • 56 investors on this round.
  4. Series D+$233.9M2018-02-13
    • Raised 9 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 104 investors on this round.
  5. Series D+$47.7M2019-05-10
    • Raised 15 mo later, in step with the ~14 mo sector norm.
    • Round 4.9× smaller than the prior — bridge or down round.
    • 50 investors on this round.
  6. Series D+$14.6M2019-06-25
    • Came back fast: 2 mo vs the ~14 mo sector norm.
    • Round 3.3× smaller than the prior — bridge or down round.
    • 4 investors on this round.
  7. Series D+$45.2M2019-06-28
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 3.1× larger than the prior — scaling up.
    • 39 investors on this round.
  8. Series D+$26.4M2021-02-23
    • Raised 20 mo later, in step with the ~14 mo sector norm.
    • Round 1.7× smaller than the prior — bridge or down round.
    • 2 investors on this round.
  9. Series D+$12.6M2021-03-17
    • Came back fast: 1 mo vs the ~14 mo sector norm.
    • Round 2.1× smaller than the prior — bridge or down round.
    • 27 investors on this round.
  10. Series C$52.5M2022-06-30
    • Raised 15 mo later, in step with the ~14 mo sector norm.
    • Round 4.2× larger than the prior — scaling up.
    • 232 investors on this round.
  11. Series D+$232.7M2022-06-30
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 4.4× larger than the prior — scaling up.
    • 645 investors on this round.
  12. Series C$62.5M2022-06-30
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 3.7× smaller than the prior — bridge or down round.
    • 233 investors on this round.
  13. Growth/Late$719.8M2024-02-22
    • Raised 20 mo later, in step with the ~14 mo sector norm.
    • Round 11.5× larger than the prior — scaling up.
    • 7 investors on this round.
Intelligence
2024 ~Q4
Modeled next raise · ~10mo cadence
$2.2B
Modeled next size est.range $1.4B$3.5B
11.5×
Last step-up
$156.8M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Ryan Drant23 other2014-05
Mohamad Makhzoumi9 other2014-05
Jeffrey Immelt4 other2019-05
Richard Whitney4 other2014-05
Anthony Gabriel1 other2014-05
Geoffrey Clark1 other2021-02
Joseph Mello1 other2019-05
Kavita C. Patel1 other2018-02
Kavita Patel1 other2019-05
Robert Sheehy1 other2019-05
Andrew Litt2022-06
Anthony C. Gabriel2017-05
Basak Ertan2019-05
Brian Stern2022-06
Cameron Cleeton2019-05
Caren Weakley2022-06
David Bassin2022-06
Denis Zerr2019-06
G. Philip Reger2019-05
Gregory Conno2024-02
Gregory Connor2019-05
Jacob Van Beek2014-05
Jamie Larsen2022-06
Jay Bronner2019-05
Registry & provenance

Radiology Partners Holdings, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1608716
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Elements Behavioral Health, Inc.Other Health CareSeries C$165.2M$1.4Bnetwork2 shared operators · same sector
Ebh Holding Company, Inc.Other Health CareSeries B$70.9M$871.1Mnetwork2 shared operators · same sector
RP Redwood Holdco, LLCOther Health CareSeed$3.9M$59.4Mnetwork2 shared operators · same sector
Mahalo Group Holdings LLCOther Health CareGrowth/Late$1.2B$4.0Bsame sector · same stage
DispatchHealth Holdings, Inc.Other Health CareSeries D+$578.0M$3.7Bnetwork1 shared operator · same sector
Genesis Healthcare, Inc.Other Health CareGrowth/Late$866.6M$10.5Bsame sector · same stage
OrangeDot, Inc.Other Health CareGrowth/Late$834.6M$14.0Bsame sector · same stage
Fovea Investment Holdings, LLCOther Health CareGrowth/Late$800.0M$8.7Bsame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Research Imaging Company, LLCOther Health CareSeries C$679.4M87%
Imaging Network, LLCOther Health CarePre-Seed$191K86%
Best Imaging, LLCOther Health CarePre-Seed$1.2M85%
Array Radiology, LLCOther Health CarePre-Seed$534K84%
Premier Imaging Holdings, LLCHospitals and PhysiciansSeries C$1.8B83%
Total Quality Imaging, LLCOther Health CarePre-Seed$273K83%
Formal Imaging Experts, LLCOther Health CarePre-Seed$423K83%
Technical Imaging Associates, LLCOther Health CarePre-Seed$746K83%
Frequently asked
How much funding has Radiology Partners Holdings, LLC raised?
Radiology Partners Holdings, LLC has raised approximately $1.5B in disclosed capital across 11 recorded financing rounds, aggregated from public filings.
What is Radiology Partners Holdings, LLC's estimated valuation?
Provath's modeled valuation for Radiology Partners Holdings, LLC is approximately $9.1B (modeled range $5.3B–$12.0B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Radiology Partners Holdings, LLC at?
Radiology Partners Holdings, LLC's latest modeled financing stage is Growth/Late. Its most recent recorded round closed around Thu Feb 22.
What does Radiology Partners Holdings, LLC do and where is it based?
Radiology Partners Holdings, LLC operates in the Other Health Care sector, based in El Segundo. Excellence in Imaging
Explore related

See where Radiology Partners Holdings, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Radiology Partners Holdings, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.